Find Cholestyramine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

88 RELATED EXCIPIENT COMPANIES

165EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Q418006
Molecular Formula
C21H30ClN
Molecular Weight
331.9  g/mol
InChI Key
KNDHRUPPBXRELB-UHFFFAOYSA-M

Cholestyramine
1 2D Structure

Cholestyramine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[4-[3-(4-ethylphenyl)butyl]phenyl]-trimethylazanium;chloride
2.1.2 InChI
InChI=1S/C21H30N.ClH/c1-6-18-9-13-20(14-10-18)17(2)7-8-19-11-15-21(16-12-19)22(3,4)5;/h9-17H,6-8H2,1-5H3;1H/q+1;/p-1
2.1.3 InChI Key
KNDHRUPPBXRELB-UHFFFAOYSA-M
2.1.4 Canonical SMILES
CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C.[Cl-]
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Q418006

2.3 Create Date
2013-02-04
3 Chemical and Physical Properties
Molecular Weight 331.9 g/mol
Molecular Formula C21H30ClN
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count1
Rotatable Bond Count6
Exact Mass331.2066777 g/mol
Monoisotopic Mass331.2066777 g/mol
Topological Polar Surface Area0 Ų
Heavy Atom Count23
Formal Charge0
Complexity300
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

API SUPPLIERS

read-more
read-more

01

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

02

Nortec Quimica

Brazil

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNortec Quimica is the largest API manufacturer in Latin America.

Flag Brazil
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Nortec Quimica

03

Purolite

United Kingdom

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmatech Expo 2025
Not Confirmed
arrow

Purolite

United Kingdom

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

04

The Dow Chemical Company

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmatech Expo 2025
Not Confirmed
arrow

The Dow Chemical Company

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

PHAEX POLYMERS PRIVATE LTD

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmatech Expo 2025
Not Confirmed
arrow

PHAEX POLYMERS PRIVATE LTD

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

06

ION EXCHANGE INDIA LIMITED

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmatech Expo 2025
Not Confirmed
arrow

ION EXCHANGE INDIA LIMITED

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF VMF Others AUDIT
blank

07

Jiangsu Kingshan New Material

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmatech Expo 2025
Not Confirmed
arrow

Jiangsu Kingshan New Material

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

THERMAX LTD CHEMICAL DIV

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmatech Expo 2025
Not Confirmed
arrow

THERMAX LTD CHEMICAL DIV

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

The Dow Chemical Company

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmatech Expo 2025
Not Confirmed
arrow

The Dow Chemical Company

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
USDMF Inactive-api CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

10

The Dow Chemical Company

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmatech Expo 2025
Not Confirmed
arrow

The Dow Chemical Company

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmatech Expo 2025
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1629138600,"product":"BULK DRUGS: CHOLESTYRAMINE RESIN USP (IO NEX SB 45)","address":"KAMALA BHUVAN NO.2, 1ST FLR. NO.37SAHAR RD., ANDHERI (E)","city":"BOMBAY ,MAHARASHTRA","supplier":"TRICON ENTERPRISES PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"JAKARTA","customer":"PNP.LAB.","customerCountry":"INDONESIA","quantity":"200.00","actualQuantity":"200","unit":"KGS","unitRateFc":"28.4","totalValueFC":"5526.2","currency":"USD","unitRateINR":2049.328,"date":"17-Aug-2021","totalValueINR":"409865.6","totalValueInUsd":"5526.2","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"3914744","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"INDONESIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"KAMALA BHUVAN NO.2, 1ST FLR. NO.37SAHAR RD., ANDHERI (E), BOMBAY ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1634668200,"product":"BULK DRUGS : COLESTYRAMINE EP (IONEX SB4","address":"KAMALA BHUVAN NO.2, 1ST FLR. NO.37SAHAR RD., ANDHERI (E)","city":"BOMBAY ,MAHARASHTRA","supplier":"TRICON ENTERPRISES PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"DUESSELDORF","customer":"FA.PH.GMB.","customerCountry":"GERMANY","quantity":"150.00","actualQuantity":"150","unit":"KGS","unitRateFc":"31","totalValueFC":"4565.4","currency":"USD","unitRateINR":2280,"date":"20-Oct-2021","totalValueINR":"342000","totalValueInUsd":"4565.4","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"5428871","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"KAMALA BHUVAN NO.2, 1ST FLR. NO.37SAHAR RD., ANDHERI (E), BOMBAY ,MAHARASHTRA","customerAddress":""}]
17-Aug-2021
20-Oct-2021
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Direct Compression

read-more
read-more

Parenteral

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Emulsifying Agents

read-more
read-more

Coating Systems & Additives

read-more
read-more

Co-Processed Excipients

read-more
read-more

API Stability Enhancers

read-more
read-more

Topical

read-more
read-more

Granulation

read-more
read-more

Rheology Modifiers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Cholestyramine Manufacturers

A Cholestyramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cholestyramine, including repackagers and relabelers. The FDA regulates Cholestyramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cholestyramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cholestyramine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cholestyramine Suppliers

A Cholestyramine supplier is an individual or a company that provides Cholestyramine active pharmaceutical ingredient (API) or Cholestyramine finished formulations upon request. The Cholestyramine suppliers may include Cholestyramine API manufacturers, exporters, distributors and traders.

click here to find a list of Cholestyramine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cholestyramine USDMF

A Cholestyramine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cholestyramine active pharmaceutical ingredient (API) in detail. Different forms of Cholestyramine DMFs exist exist since differing nations have different regulations, such as Cholestyramine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Cholestyramine DMF submitted to regulatory agencies in the US is known as a USDMF. Cholestyramine USDMF includes data on Cholestyramine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cholestyramine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Cholestyramine suppliers with USDMF on PharmaCompass.

Cholestyramine JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Cholestyramine Drug Master File in Japan (Cholestyramine JDMF) empowers Cholestyramine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Cholestyramine JDMF during the approval evaluation for pharmaceutical products. At the time of Cholestyramine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Cholestyramine suppliers with JDMF on PharmaCompass.

Cholestyramine CEP

A Cholestyramine CEP of the European Pharmacopoeia monograph is often referred to as a Cholestyramine Certificate of Suitability (COS). The purpose of a Cholestyramine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cholestyramine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cholestyramine to their clients by showing that a Cholestyramine CEP has been issued for it. The manufacturer submits a Cholestyramine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cholestyramine CEP holder for the record. Additionally, the data presented in the Cholestyramine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cholestyramine DMF.

A Cholestyramine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cholestyramine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Cholestyramine suppliers with CEP (COS) on PharmaCompass.

Cholestyramine WC

A Cholestyramine written confirmation (Cholestyramine WC) is an official document issued by a regulatory agency to a Cholestyramine manufacturer, verifying that the manufacturing facility of a Cholestyramine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cholestyramine APIs or Cholestyramine finished pharmaceutical products to another nation, regulatory agencies frequently require a Cholestyramine WC (written confirmation) as part of the regulatory process.

click here to find a list of Cholestyramine suppliers with Written Confirmation (WC) on PharmaCompass.

Cholestyramine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cholestyramine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Cholestyramine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Cholestyramine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Cholestyramine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cholestyramine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Cholestyramine suppliers with NDC on PharmaCompass.

Cholestyramine GMP

Cholestyramine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Cholestyramine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cholestyramine GMP manufacturer or Cholestyramine GMP API supplier for your needs.

Cholestyramine CoA

A Cholestyramine CoA (Certificate of Analysis) is a formal document that attests to Cholestyramine's compliance with Cholestyramine specifications and serves as a tool for batch-level quality control.

Cholestyramine CoA mostly includes findings from lab analyses of a specific batch. For each Cholestyramine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Cholestyramine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cholestyramine EP), Cholestyramine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cholestyramine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty